Dr. Kim McDowell has been appointed to oversee the regulatory affairs of the Program for Advanced Cell Therapy (PACT).
Her main duties will include crafting and managing investigational new drug (IND) and investigational device exemption (IDE) applications for PACT-sponsored clinical trials and regulatory compliance.
“Dr. McDowell brings with her the perfect combination of scientific and medical knowledge, FDA expertise, and passion for our program,” said Jacques Galipeau, MD, PACT director and associate dean of therapeutics development in the UW School of Medicine and Public Health.
Read the full article at: https://www.med.wisc.edu/news-and-events/2019/july/kim-mcdowell-named-pact-associate-director/